Bone Therapeutics knee osteoarthritis Phase III study misses primary endpoints
August 31, 2021Manufacturing and Production
Bone Therapeutics, the cell therapy company addressing unmet medical needs in orthopaedics and other diseases, announced that the Phase III …
AlzeCure’s Alzheimer’s project receives approval to start phase I study
August 31, 2021Manufacturing and Production
AlzeCure Pharma AB, a pharmaceutical company that develops a broad portfolio of candidate drugs for diseases affecting the central nervous …
New Zealand woman dies after receiving Pfizer COVID vaccine
August 31, 2021Manufacturing and Production
New Zealand has reported what they believe to be the first death associated with the Pfizer vaccine. An independent vaccine …
Blood-clot risk “substantially higher” from COVID than from jabs
August 27, 2021Medical Communications
The risks of developing a blood clot are “substantially higher” after catching coronavirus than following a COVID vaccine, research shows. …
UCB’s bimekizumab granted marketing authorisation by MHRA for plaque psoriasis
August 27, 2021Medical Communications
UCB’s bimekizumab has been granted marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of …
NICE rejects combination treatment for multiple myeloma
August 27, 2021Medical Communications
NICE does not recommend daratumumab (Darzalex, Janssen Cilag), plus bortezomib, thalidomide and dexamethasone, as a treatment option for untreated multiple …
CARMAT’s artificial heart commercially implanted successfully for third time
August 27, 2021Medical Communications
CARMAT’s artificial heart, Aeson, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, has been …
New PPE mask range can begin to kill SARS-CoV-2 on contact
August 27, 2021Medical Communications
A new PPE mask range has been launched that can begin to kill SARS-CoV-2 and other viruses and pathogens on …
Genetic cause of endometriosis identified alongside potential drug target
August 26, 2021New research, published in Science Translational Medicine, has identified the genetic cause of endometriosis which in turn has identified a …
Malaria sickness could be cut by 70%, study finds
August 26, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have found a new approach to protecting young African …
Positive Phase III trial results for AstraZeneca in flushing copper from tissues
August 26, 2021AstraZeneca’s ALXN1840 demonstrated approximately three times greater copper mobilisation from tissues than standard-of-care treatments.Results from the FoCus Phase III trial …
NHS blood tests halted due to vial shortages
August 26, 2021The NHS has suspended some blood testing due to a shortage in collection tube supplies following warnings from Becton Dickinson …
NHS England planning for possible jab roll out to 12-15 year-olds
August 26, 2021NHS England is preparing for a possible extension of the COVID vaccination programme to all 12 to 15-year-olds.This will be …
Trial planned to investigate ketamine in treatment-resistant depression
August 25, 2021Research and Development
HMNC Brain Health and Develco Pharma have partnered to develop an investigational oral prolonged-release formulation of ketamine, targeting treatment-resistant depression …
Stelis Biopharma appoints Mark Womack as new CEO
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.Womack is also the …
PureTech appoints Julie Krop as Chief Medical Officer
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.Krop will oversee all clinical development, Regulatory, CMC, and …
Tracey Lodie appointed Chief Scientific Officer of Quell Therapeutics
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Quell Therapeutics has announced the appointment of Tracey Lodie as Chief Scientific Officer.Dr Lodie brings to Quell more than 20 …
RareCan appoints Dr Anita Cooper as Non-Executive Director
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.Cooper has over 30 years’ experience in global business …
Laura Steele appointed President and General Manager for Lilly UK
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Eli Lilly and Company have announced that Laura Steele has been appointed President and General Manager (GM) for UK, Ireland …
Medical cannabis: The next innovation in oncology?
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp …
Latest content
